Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  GenMark Diagnostics, Inc    GNMK

GENMARK DIAGNOSTICS, INC (GNMK)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/12/2018 06/13/2018 06/14/2018 06/15/2018 06/18/2018 Date
7.13(c) 7.22(c) 7.31(c) 7.28(c) 7.3(c) Last
313 153 410 635 345 600 615 729 275 446 Volume
+1.57% +1.26% +1.25% -0.41% +0.27% Change
More quotes
Financials (USD)
Sales 2018 71,0 M
EBIT 2018 -43,1 M
Net income 2018 -46,5 M
Debt 2018 2,50 M
Yield 2018 -
Sales 2019 88,2 M
EBIT 2019 -34,5 M
Net income 2019 -38,6 M
Debt 2019 7,00 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 5,71x
EV / Sales2019 4,65x
Capitalization 403 M
More Financials
Company
GenMark Diagnostics, Inc. is a molecular diagnostics company, which engages in the development and commercialization of proprietary eSensor electrochemical detection technology.It also manufactures, sells, and supports instruments and molecular tests.The company was founded by Jon Faiz Kayyem on... 
More about the company
Surperformance© ratings of GenMark Diagnostics, Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on GENMARK DIAGNOSTICS, INC
06/06GenMark Diagnostics to Present at the William Blair 38th Annual Growth Stock ..
GL
05/31GENMARK DIAGNOSTICS, INC. : Submission of Matters to a Vote of Security Holders ..
AQ
05/03GENMARK DIAGNOSTICS : to Present at the Bank of America Merrill Lynch 2018 Healt..
AQ
05/02GenMark Diagnostics to Present at the Bank of America Merrill Lynch 2018 Heal..
GL
05/01GENMARK DIAGNOSTICS : 1Q Earnings Snapshot
AQ
05/01GENMARK DIAGNOSTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIO..
AQ
05/01GENMARK DIAGNOSTICS, INC. : Results of Operations and Financial Condition (form ..
AQ
05/01GenMark Diagnostics Reports First Quarter 2018 Results
GL
04/17GenMark Diagnostics Schedules First Quarter Financial Results Conference Call..
GL
03/29$1.77 EPS Expected for Asbury Automotive Group, Inc. (ABG); 5 Bullish Analyst..
AQ
More news
Sector news : Advanced Medical Equipment & Technology - NEC
06/18How U.S. tax reform rewards companies that shift profit to tax havens
RE
06/14STRYKER : Says It Isn't in Deal Talks -- WSJ
DJ
06/13STRYKER : Says It Isn't in Deal Talks With Boston Scientific -- Update
DJ
06/13STRYKER : Says It's Not in Deal Talks with Boston Scientific
DJ
06/12STRYKER : Approaches Rival Boston Scientific for Deal -- WSJ
DJ
More sector news : Advanced Medical Equipment & Technology - NEC
Latest Tweets
06/17GenMark Diagnostics $GNMK vs. Alliqua Biomedical $ALQA Head to Head Analysis .. 
06/14Contrasting Alphatec $ATEC & GenMark Diagnostics $GNMK  
06/14Contrasting Alphatec $ATEC & GenMark Diagnostics $GNMK  
06/14Alphatec $ATEC & GenMark Diagnostics $GNMK Head to Head Review  
06/12GenMark Diagnostics $GNMK Cut to “Buy” at BidaskClub  
More tweets
Qtime:90
News from SeekingAlpha
05/14WEEK 20 BREAKOUT FORECAST : Short-Term Picks To Give You An Edge 
05/01GenMark Diagnostics' (GNMK) CEO Hany Massarany on Q1 2018 Results - Earnings .. 
05/01GenMark Diagnostics beats by $0.01, beats on revenue 
04/18Midday Gainers / Losers (04/18/2018) 
04/10Snap Is Going Nowhere - Cramer's Lightning Round (4/9/18) 
Chart GENMARK DIAGNOSTICS, INC
Duration : Period :
GenMark Diagnostics, Inc Technical Analysis Chart | GNMK | US3723091043 | 4-Traders
Technical analysis trends GENMARK DIAGNOSTICS, INC
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 10,0 $
Spread / Average Target 37%
EPS Revisions
Managers
NameTitle
Hany Massarany President, Chief Executive Officer & Director
James Charles Fox Chairman
Brian Mitchell Senior Vice President-Operations
Scott Mendel CFO & Principal Accounting Office
Daryl Jay Faulkner Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
GENMARK DIAGNOSTICS, INC74.58%403
THERMO FISHER SCIENTIFIC13.65%86 821
DANAHER CORPORATION10.22%71 471
INTUITIVE SURGICAL34.40%55 570
BOSTON SCIENTIFIC CORPORATION32.96%45 479
ILLUMINA32.16%42 446